Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
Source: SeekingAlpha
2026-02-11 10:00:00 ET
It takes all the running you can do to keep in the same place. If you want to get somewhere else, you must run at least twice as fast!
—Through the Looking-Glass (Lewis Carroll)
Looking Back
About 1.5 years ago, I opened a Long position in Bristol-Myers Squibb Company ( BMY ) and wrote a bullish article called ' Don't Let The Market Fool You .'...
Read the full article on Seeking Alpha
For further details see:
Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
Novartis Ag Basel Akt
NASDAQ: NVSEF
NVSEF Trading
-6.09% G/L:
$158 Last:
268 Volume:
$158 Open:
NVSEF Latest News
February 25, 2026 07:00:00 am
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next?generation treatments to patients
February 06, 2026 12:00:00 pm
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
January 09, 2026 10:30:00 am
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
December 12, 2025 07:00:00 am
Novartis breaks ground on flagship manufacturing hub in North Carolina
NVSEF Stock Data
$299,675,221,187
2,118,043,712
N/A
1352
N/A
Pharmaceuticals
Healthcare
CH
Basel
